da Silva Morais A., Ferreira C., Teixeira M., and Lucas C.,  "The yeast Saccharomyces cerevisiae is sensitive to colorectal cancer routine treatment anti-EGFR antibody Cetuximab®",  Microbiotec11, 2011.